130 related articles for article (PubMed ID: 38445916)
1. Improved survival of patients receiving immunotherapy and chemotherapy following curative-intent resection of colorectal liver metastases.
Pollini T; Tran T; Wong P; Adam MA; Alseidi A; Corvera C; Hirose K; Nakakura E; Warren R; Maker VK; Maker AV
J Gastrointest Surg; 2024 Mar; 28(3):246-251. PubMed ID: 38445916
[TBL] [Abstract][Full Text] [Related]
2. [Long-term outcomes of patients undergoing hepatectomy for bilateral multiple colorectal liver metastases-a propensity score matching analysis].
Bao Q; Wang K; Wang HW; Jin KM; Xing BC
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Oct; 23(10):976-983. PubMed ID: 33053993
[No Abstract] [Full Text] [Related]
3. Impact of Immunotherapy after Resection of Pancreatic Cancer.
Tran TB; Maker VK; Maker AV
J Am Coll Surg; 2019 Jul; 229(1):19-27.e1. PubMed ID: 30742911
[TBL] [Abstract][Full Text] [Related]
4. Optimal policy tree to assist in adjuvant therapy decision-making after resection of colorectal liver metastases.
Endo Y; Alaimo L; Moazzam Z; Woldesenbet S; Lima HA; Yang J; Munir MM; Shaikh CF; Azap L; Katayama E; Rueda BO; Guglielmi A; Ruzzenente A; Aldrighetti L; Alexandrescu S; Kitago M; Poultsides G; Sasaki K; Aucejo F; Pawlik TM
Surgery; 2024 Mar; 175(3):645-653. PubMed ID: 37778970
[TBL] [Abstract][Full Text] [Related]
5. Significance of postoperative adjuvant chemotherapy with an oxaliplatin-based regimen after simultaneous curative resection for colorectal cancer and synchronous colorectal liver metastasis: a propensity score matching analysis.
Sugimoto K; Sakamoto K; Ii Y; Amemiya K; Sugo H; Ito T; Munakata S; Takahashi M; Kojima Y; Tomiki Y; Sato K; Saiura A; Kawasaki S
BMC Surg; 2021 Apr; 21(1):188. PubMed ID: 33836701
[TBL] [Abstract][Full Text] [Related]
6. Adjuvant chemotherapy after resection of colorectal liver metastases in patients at high risk of hepatic recurrence: a comparative study between hepatic arterial infusion of oxaliplatin and modern systemic chemotherapy.
Goéré D; Benhaim L; Bonnet S; Malka D; Faron M; Elias D; Lefèvre JH; Deschamps F; Dromain C; Boige V; Dumont F; De Baere T; Ducreux M
Ann Surg; 2013 Jan; 257(1):114-20. PubMed ID: 23235397
[TBL] [Abstract][Full Text] [Related]
7. Hepatectomy is associated with improved oncologic outcomes in recurrent colorectal liver metastases: A propensity-matched analysis.
Sutton TL; Wong LH; Walker BS; Dewey EN; Eil R; Lopez CD; Kardosh A; Chen EY; Rocha FG; Billingsley KG; Mayo SC
Surgery; 2023 Jun; 173(6):1314-1321. PubMed ID: 36435651
[TBL] [Abstract][Full Text] [Related]
8. Postoperative hepatic arterial chemotherapy in high-risk patients as adjuvant treatment after resection of colorectal liver metastases - a randomized phase II/III trial - PACHA-01 (NCT02494973).
Goéré D; Pignon JP; Gelli M; Elias D; Benhaim L; Deschamps F; Caramella C; Boige V; Ducreux M; de Baere T; Malka D
BMC Cancer; 2018 Aug; 18(1):787. PubMed ID: 30081865
[TBL] [Abstract][Full Text] [Related]
9. Conversion therapy with the intent to perform radical local treatment may not be suitable for patients with 10 or more liver metastases from colorectal cancer.
Lin J; Sun H; Zhang W; Hong Z; Lu Z; Pan Z; Hou Z; Peng J
Cancer Med; 2022 Nov; 11(22):4225-4235. PubMed ID: 35466587
[TBL] [Abstract][Full Text] [Related]
10. Adjuvant hepatic arterial infusion pump chemotherapy and resection versus resection alone in patients with low-risk resectable colorectal liver metastases - the multicenter randomized controlled PUMP trial.
Buisman FE; Homs MYV; Grünhagen DJ; Filipe WF; Bennink RJ; Besselink MGH; Borel Rinkes IHM; Bruijnen RCG; Cercek A; D'Angelica MI; van Delden OM; Donswijk ML; van Doorn L; Doornebosch PG; Emmering J; Erdmann JI; IJzerman NS; Grootscholten C; Hagendoorn J; Kemeny NE; Kingham TP; Klompenhouwer EG; Kok NFM; Koolen S; Kuhlmann KFD; Kuiper MC; Lam MGE; Mathijssen RHJ; Moelker A; Oomen-de Hoop E; Punt CJA; Te Riele WW; Roodhart JML; Swijnenburg RJ; Prevoo W; Tanis PJ; Vermaas M; Versleijen MWJ; Veuger FP; Weterman MJ; Verhoef C; Groot Koerkamp B
BMC Cancer; 2019 Apr; 19(1):327. PubMed ID: 30953467
[TBL] [Abstract][Full Text] [Related]
11. Predicting Limited Survival After Resection of Synchronous Colorectal Liver Metastases: a Propensity Score Matched Comparison Between The Primary First And The Simultaneous Strategy.
Addeo P; Foguenne M; Guerra M; Cusumano C; Paul C; Faitot F; Fiore L; De Mathelin P; Bachellier P
J Gastrointest Surg; 2023 Jun; 27(6):1141-1151. PubMed ID: 36857012
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of Adjuvant Chemotherapy Following Curative Resection of Colorectal Cancer Liver Metastases.
Takeda K; Kikuchi Y; Sawada YU; Kumamoto T; Watanabe J; Kuniski C; Misumi T; Endo I
Anticancer Res; 2022 Nov; 42(11):5497-5505. PubMed ID: 36288891
[TBL] [Abstract][Full Text] [Related]
13. Adjuvant systemic chemotherapy after putative curative resection of colorectal liver and lung metastases.
Brandi G; Derenzini E; Falcone A; Masi G; Loupakis F; Pietrabissa A; Pinna AD; Ercolani G; Pantaleo MA; Di Girolamo S; Grazi GL; de Rosa F; Biasco G
Clin Colorectal Cancer; 2013 Sep; 12(3):188-94. PubMed ID: 23773458
[TBL] [Abstract][Full Text] [Related]
14. Is complete liver resection without resection of synchronous lung metastases justified?
Mise Y; Kopetz S; Mehran RJ; Aloia TA; Conrad C; Brudvik KW; Taggart MW; Vauthey JN
Ann Surg Oncol; 2015 May; 22(5):1585-92. PubMed ID: 25373535
[TBL] [Abstract][Full Text] [Related]
15. Bevacizumab improves survival in patients with synchronous colorectal liver metastases provided the primary tumor is resected first.
Lim C; Doussot A; Osseis M; Esposito F; Salloum C; Calderaro J; Tournigand C; Azoulay D
Clin Transl Oncol; 2018 Oct; 20(10):1274-1279. PubMed ID: 29594943
[TBL] [Abstract][Full Text] [Related]
16. Adjuvant Hepatic Artery Infusion Chemotherapy is Associated With Improved Survival Regardless of KRAS Mutation Status in Patients With Resected Colorectal Liver Metastases: A Retrospective Analysis of 674 Patients.
Gholami S; Kemeny NE; Boucher TM; Gönen M; Cercek A; Kingham TP; Balachandran V; Allen P; DeMatteo R; Drebin J; Jarnagin W; D'Angelica M
Ann Surg; 2020 Aug; 272(2):352-356. PubMed ID: 32675549
[TBL] [Abstract][Full Text] [Related]
17. The effect of a primary tumour resection on the progression of synchronous colorectal liver metastases: an exploratory study.
Slesser AA; Khan F; Chau I; Khan AZ; Mudan S; Tekkis PP; Brown G; Rao S
Eur J Surg Oncol; 2015 Apr; 41(4):484-92. PubMed ID: 25638603
[TBL] [Abstract][Full Text] [Related]
18. Long-term survival after liver resection for colorectal liver metastases in patients with hepatic pedicle lymph nodes involvement in the era of new chemotherapy regimens.
Oussoultzoglou E; Romain B; Panaro F; Rosso E; Pessaux P; Bachellier P; Jaeck D
Ann Surg; 2009 Jun; 249(6):879-86. PubMed ID: 19474695
[TBL] [Abstract][Full Text] [Related]
19. Activating KRAS mutation is prognostic only among patients who receive preoperative chemotherapy before resection of colorectal liver metastases.
Margonis GA; Kim Y; Sasaki K; Samaha M; Buettner S; Amini N; Pawlik TM
J Surg Oncol; 2016 Sep; 114(3):361-7. PubMed ID: 27264476
[TBL] [Abstract][Full Text] [Related]
20. Preoperative Chemotherapy and Resection Margin Status in Colorectal Liver Metastasis Patients: A Propensity Score-Matched Analysis.
Solaini L; Gardini A; Passardi A; Mirarchi MT; D'Acapito F; La Barba G; Cucchi M; Casadei Gardini A; Frassineti GL; Cucchetti A; Ercolani G
Am Surg; 2019 May; 85(5):488-493. PubMed ID: 31126361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]